Zentalis Pharmaceuticals (ZNTL) Other Operating Expenses (2023 - 2025)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Other Operating Expenses of -$4000.0 for Q1 2025, down 100.11% quarter-over-quarter from $3.7 million in Q4 2024.
Zentalis Pharmaceuticals (ZNTL) Other Operating Expenses (2023 - 2025) Analysis & Trends
Zentalis Pharmaceuticals' Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$4000.0 for Q1 2025.
- In Q1 2025, Other Operating Expenses changed N/A year-over-year to -$4000.0; the TTM figure through Dec 2025 stood at -$4000.0 (down 100.11% YoY), while the FY2024 annual figure was $3.7 million, down 91.8% from the prior year.
- Other Operating Expenses for Q1 2025 stood at -$4000.0, down from $3.7 million in the prior quarter.
- The five-year high for Other Operating Expenses was $45.6 million in Q2 2023, with the low at -$4000.0 in Q1 2025.
- The 3-year median for Other Operating Expenses is $3.7 million (2024), against an average of $16.4 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | 3.74 Mn |
| Jun 30, 2023 | 45.57 Mn |